To assess the frequency and genetic predispositions of concurrent immu
nological diseases and immunoserological markers in autoimmune hepatit
is and chronic viral hepatitis, we assessed 185 patients prospectively
, including 122 patients with autoimmune hepatitis and 63 patients wit
h viral disease. Human leukocyte antigens were determined in all patie
nts. Sixty patients (32%) had concurrent immunological diseases, and t
he majority of the diseases (68%) had known human leukocyte antigen as
sociations. Although patients with autoimmune hepatitis had concurrent
immunological diseases more commonly than those with viral disease (3
8% vs. 22%; p = 0.04), the nature of the diseases was similar in both
groups, as were the frequencies of human leukocyte antigen-DR4 (42% vs
. 39%; p = 0.7). The presence of human leukocyte antigen-DR4 was assoc
iated with the concurrence of immunological diseases in both autoimmun
e (62% vs. 33%; p = 0.0 1) and viral hepatitis (75% vs. 29%; p = 0.009
). In autoimmune hepatitis, human leukocyte antigen-DR4 was also assoc
iated with the expression of smooth muscle antibodies and high-titer a
ntinuclear antibodies. We conclude that concurrent immunological disea
ses and immunoserological markers are common in autoimmune and chronic
viral hepatitis. Both conditions have a common genetic predisposition
for concurrent immunological disease associated with human leukocyte
antigen-DR4. The expression of smooth muscle antibodies and high-titer
antinuclear antibodies is associated with human leukocyte antigen-DR4
in autoimmune hepatitis only, suggesting that this response is associ
ated with triggering antigens and immune recognition systems that are
different from those in viral disease.